BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Simonato M, Agoston DV, Brooks-Kayal A, Dulla C, Fureman B, Henshall DC, Pitkänen A, Theodore WH, Twyman RE, Kobeissy FH, Wang KK, Whittemore V, Wilcox KS. Identification of clinically relevant biomarkers of epileptogenesis - a strategic roadmap. Nat Rev Neurol 2021;17:231-42. [PMID: 33594276 DOI: 10.1038/s41582-021-00461-4] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 18.0] [Reference Citation Analysis]
Number Citing Articles
1 Stredny C, Rotenberg A, Leviton A, Loddenkemper T. Systemic inflammation as a biomarker of seizure propensity and a target for treatment to reduce seizure propensity. Epilepsia Open 2023;8:221-34. [PMID: 36524286 DOI: 10.1002/epi4.12684] [Reference Citation Analysis]
2 Reynolds A, Vranic-Peters M, Lai A, Grayden DB, Cook MJ, Peterson A. Prognostic interictal electroencephalographic biomarkers and models to assess antiseizure medication efficacy for clinical practice: A scoping review. Epilepsia 2023. [PMID: 36790369 DOI: 10.1111/epi.17548] [Reference Citation Analysis]
3 Chen Y, Nagib MM, Yasmen N, Sluter MN, Littlejohn TL, Yu Y, Jiang J. Neuroinflammatory mediators in acquired epilepsy: an update. Inflamm Res 2023. [PMID: 36745211 DOI: 10.1007/s00011-023-01700-8] [Reference Citation Analysis]
4 Heiskanen M, Das Gupta S, Mills JD, van Vliet EA, Manninen E, Ciszek R, Andrade P, Puhakka N, Aronica E, Pitkänen A. Discovery and Validation of Circulating microRNAs as Biomarkers for Epileptogenesis after Experimental Traumatic Brain Injury-The EPITARGET Cohort. Int J Mol Sci 2023;24. [PMID: 36769143 DOI: 10.3390/ijms24032823] [Reference Citation Analysis]
5 Walker MC. Reactive oxygen species in status epilepticus. Epilepsia Open 2023. [PMID: 36648377 DOI: 10.1002/epi4.12691] [Reference Citation Analysis]
6 Henshall DC, Arzimanoglou A, Dedeurwaerdere S, Guerrini R, Jozwiak S, Kokaia M, Lerche H, Pitkänen A, Ryvlin P, Simonato M, Sisodiya SM. Shaping the future of European epilepsy research: Final meeting report from EPICLUSTER. Epilepsy Res 2023;189:107068. [PMID: 36549242 DOI: 10.1016/j.eplepsyres.2022.107068] [Reference Citation Analysis]
7 Rubio T, Viana R, Moreno-Estellés M, Campos-Rodríguez Á, Sanz P. TNF and IL6/Jak2 signaling pathways are the main contributors of the glia-derived neuroinflammation present in Lafora disease, a fatal form of progressive myoclonus epilepsy. Neurobiol Dis 2023;176:105964. [PMID: 36526090 DOI: 10.1016/j.nbd.2022.105964] [Reference Citation Analysis]
8 Löscher W, Stafstrom CE. Epilepsy and its neurobehavioral comorbidities: Insights gained from animal models. Epilepsia 2023;64:54-91. [PMID: 36197310 DOI: 10.1111/epi.17433] [Reference Citation Analysis]
9 Pollard BS, Wen Z, Jacobson KA, Pollard JR. Stereospecific antiseizure activity in mouse and rat epilepsy models by a pyridinium inhibitor of TNFα/NFκB signaling. European Journal of Medicinal Chemistry Reports 2022;6:100065. [DOI: 10.1016/j.ejmcr.2022.100065] [Reference Citation Analysis]
10 Jiang J, Santhakumar V, Zhu X. Editorial: Neuroinflammation in acquired epilepsy. Front Cell Dev Biol 2022;10. [DOI: 10.3389/fcell.2022.1074537] [Reference Citation Analysis]
11 Li M, Liu Y, Liu Y, Pu C, Yin R, Zeng Z, Deng L, Wang X. Resting-state EEG-based convolutional neural network for the diagnosis of depression and its severity. Front Physiol 2022;13:956254. [DOI: 10.3389/fphys.2022.956254] [Reference Citation Analysis]
12 Guarino A, Bettegazzi B, Aziz N, Barbieri M, Bochicchio D, Crippa L, Marino P, Sguizzato M, Soukupova M, Zucchini S, Simonato M. Low-dose 7,8-Dihydroxyflavone Administration After Status Epilepticus Prevents Epilepsy Development. Neurotherapeutics 2022;19:1951-65. [PMID: 36180719 DOI: 10.1007/s13311-022-01299-4] [Reference Citation Analysis]
13 Chen Y, Galea I, Macdonald RL, Wong GKC, Zhang JH. Rethinking the initial changes in subarachnoid haemorrhage: Focusing on real-time metabolism during early brain injury. eBioMedicine 2022;83:104223. [DOI: 10.1016/j.ebiom.2022.104223] [Reference Citation Analysis]
14 Oliveira MET, Paulino GVB, Dos Santos Júnior ED, da Silva Oliveira FA, Melo VMM, Ursulino JS, de Aquino TM, Shetty AK, Landell MF, Gitaí DLG. Multi-omic Analysis of the Gut Microbiome in Rats with Lithium-Pilocarpine-Induced Temporal Lobe Epilepsy. Mol Neurobiol 2022. [PMID: 35962889 DOI: 10.1007/s12035-022-02984-3] [Reference Citation Analysis]
15 Löscher W. Dogs as a Natural Animal Model of Epilepsy. Front Vet Sci 2022;9:928009. [DOI: 10.3389/fvets.2022.928009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Casillas-espinosa PM, Anderson A, Harutyunyan A, Li C, Lee J, Braine EL, Brady RD, Sun M, Huang C, Barlow CK, Shah AD, Schittenhelm RB, Mychasiuk R, Jones NC, Shultz SR, O’brien TJ. Disease-modifying effects of sodium selenate in a model of drug-resistant, temporal lobe epilepsy.. [DOI: 10.1101/2022.05.17.492323] [Reference Citation Analysis]
17 Shehta N, Kamel AE, Sobhy E, Ismail MH. Malondialdehyde and superoxide dismutase levels in patients with epilepsy: a case–control study. Egypt J Neurol Psychiatry Neurosurg 2022;58. [DOI: 10.1186/s41983-022-00479-5] [Reference Citation Analysis]
18 Forster RJ, Henshall DC, El Naggar H, Pellegrin Y, Delanty N. Electrochemiluminescent Detection of Epilepsy Biomarker miR-134 using a Metal Complex Light Switch. Bioelectrochemistry 2022. [DOI: 10.1016/j.bioelechem.2022.108150] [Reference Citation Analysis]
19 Costa A, Lo Barco T, Spezia E, Conti V, Roli L, Marini L, Minghetti S, Caramaschi E, Pietrangelo L, Pecoraro L, D’achille F, Accorsi P, Trenti T, Melani F, Marini C, Guerrini R, Darra F, Bergonzini P, Biagini G. Prospective Evaluation of Ghrelin and Des-Acyl Ghrelin Plasma Levels in Children with Newly Diagnosed Epilepsy: Evidence for Reduced Ghrelin-to-Des-Acyl Ghrelin Ratio in Generalized Epilepsies. JPM 2022;12:527. [DOI: 10.3390/jpm12040527] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
20 Golub VM, Reddy DS. Post-Traumatic Epilepsy and Comorbidities: Advanced Models, Molecular Mechanisms, Biomarkers, and Novel Therapeutic Interventions. Pharmacol Rev 2022;74:387-438. [PMID: 35302046 DOI: 10.1124/pharmrev.121.000375] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
21 Ngadimon IW, Aledo-serrano A, Arulsamy A, Mohan D, Khoo CS, Cheong WL, Shaikh MF. An Interplay Between Post-Traumatic Epilepsy and Associated Cognitive Decline: A Systematic Review. Front Neurol 2022;13:827571. [DOI: 10.3389/fneur.2022.827571] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Eid T. Harnessing Metabolomics to Advance Epilepsy Research. Epilepsy Curr. [DOI: 10.1177/15357597221074518] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Nami M, Thatcher R, Kashou N, Lopes D, Lobo M, Bolanos JF, Morris K, Sadri M, Bustos T, Sanchez GE, Mohd-Yusof A, Fiallos J, Dye J, Guo X, Peatfield N, Asiryan M, Mayuku-Dore A, Krakauskaite S, Soler EP, Cramer SC, Besio WG, Berenyi A, Tripathi M, Hagedorn D, Ingemanson M, Gombosev M, Liker M, Salimpour Y, Mortazavi M, Braverman E, Prichep LS, Chopra D, Eliashiv DS, Hariri R, Tiwari A, Green K, Cormier J, Hussain N, Tarhan N, Sipple D, Roy M, Yu JS, Filler A, Chen M, Wheeler C, Ashford JW, Blum K, Zelinsky D, Yamamoto V, Kateb B. A Proposed Brain-, Spine-, and Mental- Health Screening Methodology (NEUROSCREEN) for Healthcare Systems: Position of the Society for Brain Mapping and Therapeutics. J Alzheimers Dis 2022;86:21-42. [PMID: 35034899 DOI: 10.3233/JAD-215240] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
24 Gan X, Angelina E, Gu F, Zheng K, Cui L. Arginine–malate-based dual-emission carbon dots for uric acid determination in human serum with a miniaturized device. J Mater Sci 2022;57:576-88. [DOI: 10.1007/s10853-021-06660-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Baravkar AA, D. Shinde S, Aher NB. ROLE OF BIOMARKERS IN EPILEPTOGENESIS: A CONCISE REVIEW. Int J Pharm Pharm Sci 2022. [DOI: 10.22159/ijpps.2022v14i1.43306] [Reference Citation Analysis]
26 Shen Y, Gong Y, Ruan Y, Chen Z, Xu C. Secondary Epileptogenesis: Common to See, but Possible to Treat? Front Neurol 2021;12:747372. [PMID: 34938259 DOI: 10.3389/fneur.2021.747372] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
27 Hwang Y, Kadam SD. Targeting Epileptogenesis: A Conceptual Black Hole or Light at the End of the Tunnel? Epilepsy Curr 2021;21:372-5. [PMID: 34924840 DOI: 10.1177/15357597211030384] [Reference Citation Analysis]
28 Hutchinson E, Osting S, Rutecki P, Sutula T. Diffusion Tensor Orientation as a Microstructural MRI Marker of Mossy Fiber Sprouting After TBI in Rats. J Neuropathol Exp Neurol 2021:nlab123. [PMID: 34865073 DOI: 10.1093/jnen/nlab123] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Tiedt S. Epileptische Anfälle bei Schlaganfall. InFo Neurologie 2021;23:52-61. [DOI: 10.1007/s15005-021-2108-0] [Reference Citation Analysis]
30 Xu K, Jiang X, Ariston Gabriel AN, Li X, Wang Y, Xu S. Evolving Landscape of Long Non-coding RNAs in Cerebrospinal Fluid: A Key Role From Diagnosis to Therapy in Brain Tumors. Front Cell Dev Biol 2021;9:737670. [PMID: 34692695 DOI: 10.3389/fcell.2021.737670] [Reference Citation Analysis]
31 Moon J. Epilepsy Care in the Precision Medicine Era. Epilia: Epilepsy Commun 2021;3:74-77. [DOI: 10.35615/epilia.2021.00284] [Reference Citation Analysis]
32 Perucca E. The pharmacological treatment of epilepsy: recent advances and future perspectives. Acta Epileptologica 2021;3. [DOI: 10.1186/s42494-021-00055-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
33 French JA, Bebin M, Dichter MA, Engel J Jr, Hartman AL, Jóźwiak S, Klein P, McNamara J Sr, Twyman R, Vespa P. Antiepileptogenesis and disease modification: Clinical and regulatory issues. Epilepsia Open 2021;6:483-92. [PMID: 34270884 DOI: 10.1002/epi4.12526] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
34 Dulla CG, Pitkänen A. Novel Approaches to Prevent Epileptogenesis After Traumatic Brain Injury. Neurotherapeutics 2021;18:1582-601. [PMID: 34595732 DOI: 10.1007/s13311-021-01119-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
35 Löscher W, Klein P. New approaches for developing multi-targeted drug combinations for disease modification of complex brain disorders. Does epilepsy prevention become a realistic goal? Pharmacol Ther 2021;:107934. [PMID: 34216705 DOI: 10.1016/j.pharmthera.2021.107934] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
36 Kumar U, Li L, Bragin A, Engel J Jr. Spike and wave discharges and fast ripples during posttraumatic epileptogenesis. Epilepsia 2021;62:1842-51. [PMID: 34155626 DOI: 10.1111/epi.16958] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
37 Galanopoulou AS, Löscher W, Lubbers L, O'Brien TJ, Staley K, Vezzani A, D'Ambrosio R, White HS, Sontheimer H, Wolf JA, Twyman R, Whittemore V, Wilcox KS, Klein B. Antiepileptogenesis and disease modification: Progress, challenges, and the path forward-Report of the Preclinical Working Group of the 2018 NINDS-sponsored antiepileptogenesis and disease modification workshop. Epilepsia Open 2021;6:276-96. [PMID: 34033232 DOI: 10.1002/epi4.12490] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]